CoChat

The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders

Open access
Kantor, Boris, O’Donovan, Bernadette, Rittiner, Joseph, Hodgson, Dellila, Lindner, Nicholas, Guerrero, Sophia, Dong, Wendy, Zhang, Austin, Chiba-Falek, Ornit · 2024 · Nature Communications
Cited by 38

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Safely and efficiently controlling gene expression is a long-standing goal of biomedical research, and CRISPR/Cas system can be harnessed to create powerful tools for epigenetic editing. Adeno-associated-viruses (AAVs) represent the delivery vehicle of choice for therapeutic platform. However, their small packaging capacity isn’t suitable for large constructs including most CRISPR/dCas9-effector vectors. Thus, AAV-based CRISPR/Cas systems have been delivered via two separate viral vectors. Here we develop a compact CRISPR/dCas9-based repressor system packaged in AAV as a single optimized vector. The system comprises the small Staphylococcus aureus (Sa)dCas9 and an engineered repressor molecule, a fusion of MeCP2’s transcription repression domain (TRD) and KRAB. The dSaCas9-KRAB-MeCP2(TRD) vector platform repressed robustly and sustainably the expression of multiple genes-of-interest, in vitro and in vivo, including ApoE, the strongest genetic risk factor for late onset Alzheimer’s disease (LOAD). Our platform broadens the CRISPR/dCas9 toolset available for transcriptional manipulation of gene expression in research and therapeutic settings. Adeno-associated vectors (AAVs) are frequently used for the delivery of genetic cargo but their small packaging capacity is not suitable for delivery of large constructs, including most CRISPR/dCas9-effector systems. Here the authors report a compact dCas9-based repressor system packaged within a single, optimized AAV vector.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-024-50515-6

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 38

Metadata

Authors
Kantor, B., O’Donovan, B., Rittiner, J., Hodgson, D., Lindner, N., Guerrero, S., Dong, W., Zhang, A., & Chiba-Falek, O.
Venue
Nature Communications
Published
2024-08-23
Volume
15
Issue
1
Pages
7259-7259
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4401805239
Cited by
38
References
28
FWCI
4.30
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders. https://app.cochat.ai/papers/10.1038/s41467-024-50515-6
The paper
Kantor, B., O’Donovan, B., Rittiner, J., Hodgson, D., Lindner, N., Guerrero, S., Dong, W., Zhang, A., & Chiba-Falek, O. (2024). The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders. Nature Communications. https://doi.org/10.1038/s41467-024-50515-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.